Hence, further investigation is needed to determine whether this modified immunization regimen improves GM-CSF’s anti-tumor function and whether the combination of GM-CSF and L-pampoTM promotes robust immune response and anti-cancer efficacy. Here, CSF2 is linked to cancer.